A specific polymerase chain reaction method to identify Stenotrophomonas maltophilia by Gallo, Stephanie Wagner et al.
390
online | memorias.ioc.fiocruz.br
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 108(3): 390-391, May 2013
Stenotrophomonas maltophilia is an important 
emerging opportunistic nosocomial pathogen that is 
found in different environmental sources and it is com-
monly described as an infecting agent in immunocom-
promised, oncologic and cystic fibrosis patients (Davies 
& Rubin 2007, Looney et al. 2009). The treatment of S. 
maltophilia infection is difficult due to its intrinsic re-
sistance to important antimicrobial agents and mobile 
genetic elements, such as transposons and plasmids, 
which are frequently present and carry determinants of 
resistance inserted in integrons (Chang et al. 2004, Nico-
demo & Paez 2007, Liaw et al. 2010).
S. maltophilia is usually isolated using a selective 
medium with the addition of imipenem and other anti-
microbial agents and identified by biochemical methods 
(Foster et al. 2008a, Adjidé et al. 2010). However, the 
biochemical tests used to identify S. maltophilia, includ-
ing such commercial systems as Vitek-2, API-20NE and 
Biolog, occasionally misidentify this species as other 
non-fermentative Gram-negative bacilli (Zbinden et 
al. 2007, Pinot et al. 2011). Moreover, the current poly-
merase chain reaction (PCR)-based protocols for the 
identification of S. maltophilia have also presented limi-
tations related to low specificity due to the significant 
genetic similarity between Stenotrophomonas species 
and other non-fermentative Gram-negative bacilli (Berg 
et al. 1999, Foster et al. 2008b).
To overcome this problem, we developed a spe-
cific PCR protocol for the identification of S. malto-
philia based on the design of a primer pair that tar-
gets a 278 bp fragment of the 23S rRNA gene (F, 
5’GCTGGATTGGTTCTAGGAAAACGC3’, and R, 
5’ACGCAGTCACTCCTTGCG3’). The 23S rRNA gene 
was chosen due to the higher variability in this region 
among species of the Stenotrophomonas genus compared 
to the 16S rRNA gene, as determined using CLUSTALW 
software (data not shown). The primers targeting the 23S 
rRNA gene were designed based on the alignment of the 
following sequences: S. maltophilia (GenBank accession 
AF273255), Stenotrophomonas acidaminiphila ATCC 
700916T (EU878276), Stenotrophomonas nitritireducens 
ATCC BAA-12T (EU878278), Stenotrophomonas rhizo-
phila ATCC BAA-473T (EU878279), Xanthomonas axo-
nopodis pv. citri DAR 65864 (EU878280), X. axonopodis 
pv. phaseoli IAC13755 (FJ828875), Xanthomonas cam- 
pestris pv. begoniae HT1-14 (JQ337960), X. axonopo-
dis pv. poinsettiicola HN-1 (GU144282), Xanthomonas 
arboricola pv. poinsettiicola LMG 8676 (GU144280), 
X. axonopodis pv. manihotis IBSBF1994 (FJ828873), X. 
axonopodis pv. allii IBSBF1770 (FJ828871) and X. cam- 
pestris pv. campestris DAR 65808 (EU878277). The PCR 
mixture was composed of 100 ng target DNA, which was 
extracted according to Rademaker and de Bruijn (1997), 
0.2 mM each deoxynucleoside triphosphate (Ludwig Bio-
tecnologia, Alvorada, RS, Brazil), 2.5 µL 10X PCR buf-
fer (Invitrogen, São Paulo, SP, Brazil), 1.0 mM MgCl2, 
0.2 U Taq DNA polymerase (Invitrogen) and 20 µM each 
primer in a total volume of 25 µL. The amplifications 
were performed using a Veriti Thermal Cycler (Applied 
Biosystems, Carlsbad, CA, USA) with an initial denatur-
ation step at 94ºC for 5 min, followed by 30 cycles of de-
naturation at 94ºC for 45 sec, annealing at 68ºC for 45 sec 
and extension at 72ºC for 45 sec, with a final extension at 
72ºC for 10 min. The amplicons were analysed by electro-
phoresis through a 2% agarose gel. In addition, the same 
primer pair was evaluated in a real-time PCR (RT-PCR) 
assay using a Platinum SYBR Green quantitative PCR 
(qPCR) SuperMix-UDG (Invitrogen). Each 20 µL reac-
tion contained 100 ng of DNA sample, 10 μL of SYBR 
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Green qPCR SuperMix reagent (Invitrogen) and 0.2 µL 
of each primer. The amplifications were performed using 
a StepOne RT-PCR system (Applied Biosystems) with 
the same annealing temperature and cycle number used 
in the conventional PCR described above.
The following reference strains of the Stenotro- 
phomonas species and other non-fermentative Gram-
negative bacilli were used to standardise the protocol: S. 
maltophilia ATCC 13637, S. maltophilia LMG 958T, S. 
maltophilia, formerly Stenotrophomonas africana LMG 
22072 (Coenye et al. 2004), S. acidaminiphila LMG 
22073, S. nitritireducens LMG 22074, five Acinetobacter 
baumannii isolates, three Acinetobacter calcoaceticus-
baumannii complex isolates, one Burkholderia cepacia, 
five Pseudomonas aeruginosa isolates, two Pseudomo-
nas spp and X. axonopodis. Specific amplification was 
detected using both PCR methods only for the S. malto-
philia strains, including the sample previously classified 
as S. africana, whereas no amplification was observed 
for all other bacterial strains tested. The detection limits 
of RT-PCR were determined using the threshold cycle 
(Ct) values obtained from tests performed with S. malto-
philia ATCC 13637 and S. maltophilia, formerly S. afri- 
cana LMG 22072; the Ct values were 19.58 and 15.9, 
respectively. All tests were performed in duplicate. The 
standard deviation was 0.08 for both analyses. To test the 
applicability of the protocol, 100 different clinical iso-
lates of S. maltophilia, which were previously identified 
using the Vitek system (bioMérieux, Hazelwood, MO, 
USA), were evaluated and produced specific amplicons.
One amplicon obtained from S. maltophilia ATCC 
13637 was randomly chosen and sequenced using an 
ABI 3130 XL Genetic Analyzer (Applied Biosystems) 
automated DNA sequencer. The sequence was aligned 
with the S. maltophilia 23S rRNA sequences deposited 
in GenBank (AM743169 and AF273255) using MEGA 
5.10 Beta software, presenting 100% identity.
Foster et al. (2008b) and Pinot et al. (2011) reported 
the use of a different region of the 23S rRNA gene as 
a target, but their results showed cross-reaction between 
Stenotrophomonas and Xanthomonas species, demon-
strating low PCR specificity. Additionally, Pinot et al. 
(2011) developed a multiplex PCR targeting smeD and 
ggpS to differentiate S. maltophilia and S. rhizophila; al-
though this technique was successful, it did not exclude 
the cross-reaction with Xanthomonas species. In contrast, 
no cross-reaction was observed with X. axonopodis using 
the protocol described in this study. It should be noted that 
the primer pair in this study was not evaluated against 
other species of Xanthomonas and/or S. rhizophila. Other 
studies have described protocols to detect S. maltophilia 
using RT-PCR, but the cross-reaction with Xanthomonas 
and/or other Stenotrophomonas species was not evalu-
ated (Wellinghausen et al. 2004, Dark et al. 2011).
Therefore, the primers designed in this study are 
an important alternative to specifically detect S. malto-
philia using rapid molecular methods, which can enable 
the timely determination of the appropriate antimicro-
bial protocol for the successful treatment of infections 
caused by this microorganism.
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